Aigen Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,171	Closed	-$207K	–	709
2024 Q2	$207K	Buy	+5,171	New	+$214K	0.04%	616
2023 Q3	–	Sell	-8,868	Closed	-$510K	–	807
2023 Q2	$510K	Buy	8,868 +1,069	+14%	+$47.4K	0.08%	344
2023 Q1	$292K	Buy	+7,799	New	+$256K	0.04%	433
2021 Q3	–	Sell	-12,390	Closed	-$250K	–	462
2021 Q2	$250K	Sell	12,390 -3,687	-23%	-$69.5K	0.04%	359
2021 Q1	$295K	Sell	16,077 -5,195	-24%	-$96.6K	0.04%	416
2020 Q4	$428K	Sell	21,272 -2,628	-11%	-$51.1K	0.06%	434
2020 Q3	$448K	Buy	+23,900	New	+$481K	0.06%	429
2020 Q2	–	Sell	-3,134	Closed	-$47K	–	802
2020 Q1	$47K	Buy	3,134 +1,863	+147%	+$32.4K	0.01%	1002
2019 Q4	$25K	Buy	+1,271	New	+$24.4K	﹤0.01%	890